[Min Ji-Son, Edaily Reporter] Humedix is accelerating the export diversification of its brand, elravie cosmetic, through its participation in Asia’s leading international B2B beauty trade show.

Humedix, a Huons Group subsidiary specializing in aesthetic medicine, announced on Nov. 12 that it is participating in ‘Cosmoprof Asia Hong Kong 2026’, taking place at the Hong Kong Convention and Exhibition Centre (HKCEC) from Nov. 11 to 13.

‘Cosmoprof Asia’ is the largest B2B beauty exhibition in the Asia-Pacific region, gathering global beauty trendsetters to introduce their cutting-edge technologies, product innovations, and new solutions.

Humedix showcased ‘elravie cosmetic,’ a derma cosmetic brand that combines biotechnology with aesthetic expertise. The company highlighted the strengths of its 'K-derma heritage' alongside a sophisticated product portfolio ranging from basic skincare to functional products.

During the event, Humedix held meetings with multinational buyers, primarily from emerging beauty markets such as Southeast Asia and the Middle East, to discuss export opportunities for elravie cosmetic.

Building on its participation in this exhibition, Humedix plans to diversify its global export portfolio by expanding beyond the Chinese market into promising regions like Southeast Asia and the Middle East. Previously, in June, Humedix solidified its distribution channel in Greater China by signing a large-scale exclusive distribution agreement with Chinese distribution company, Grenia.

“Cosmoprof Asia Hong Kong is a pivotal event that draws a massive turnout of buyers not only from neighboring Asian countries but also from emerging markets like the Middle East,” a Humedix official said. “We will work to expand our overseas distribution network based on our R&D capabilities and expertise.”